Home News Portugal registers excess mortality Portugal registers excess mortality The Directorate-General of Health (DGS) and the National Institute of Health, Dr. Ricardo Jorge (INSA), revealed that Portugal has experienced excess mortality since the first week of December.
Portugal registers excess mortality
Monday, 12 January 2026RSS
Context & Explainers
Excess mortality is the number of deaths above what would be expected based on historical averages (commonly a multi‑year baseline), and it captures deaths directly and indirectly caused by events like epidemics, heatwaves or healthcare disruptions. Portugal’s public health institute INSA (Instituto Nacional de Saúde Doutor Ricardo Jorge) monitors excess mortality to see the broader impact of seasonal illnesses and other stresses on the health system, so a drop in flu cases does not automatically mean overall mortality has returned to normal. Those following public‑health trends should note excess‑mortality figures because they show the pandemic and other factors’ continuing effect on population health.
The DGS (Direção-Geral da Saúde) is Portugal's central public health authority, responsible for setting health policy guidelines, managing vaccination programs, disease surveillance, and public health campaigns. It operates under the Ministry of Health.
The DGS issues clinical guidelines (normas) that health professionals across Portugal follow, manages the national vaccination schedule, coordinates responses to disease outbreaks, and publishes health statistics. It became widely known during the COVID-19 pandemic as the lead agency for public health guidance.
For residents, the DGS is the authoritative source for vaccination schedules, health alerts, and clinical guidance. Its recommendations shape how hospitals and health centers deliver care across the country.
The National Institute of Health Ricardo Jorge (Instituto Nacional de Saúde Ricardo Jorge or INSA) is Portugal's public health institute responsible for epidemiological surveillance, reference laboratories, research and technical guidance for the health system. INSA plays a central role in testing, tracking infectious diseases and issuing scientific advice used by the government and the Serviço Nacional de Saúde, so its findings often shape public-health measures and travel or testing guidance.
